Viewing StudyNCT00003361



Ignite Creation Date: 2024-05-05 @ 11:21 AM
Last Modification Date: 2024-10-26 @ 9:03 AM
Study NCT ID: NCT00003361
Status: COMPLETED
Last Update Posted: 2013-06-26
First Post: 1999-11-01

Brief Title: Decitabine in Treating Patients With Myelodysplastic Syndrome
Sponsor: Memorial Sloan Kettering Cancer Center
Organization: National Cancer Institute NCI

Conditions & Keywords Data

Conditions:
Name
Myelodysplastic Syndromes
Leukemia
Keywords:
Name View
childhood myelodysplastic syndromes View
refractory anemia View
refractory anemia with ringed sideroblasts View
refractory anemia with excess blasts View
refractory anemia with excess blasts in transformation View
chronic myelomonocytic leukemia View
de novo myelodysplastic syndromes View
previously treated myelodysplastic syndromes View
secondary myelodysplastic syndromes View